Experts in Vascular Surgery, Interventional Radiology and
Interventional Cardiology to Help Guide Commercialization
SAN
DIEGO, May 6, 2024 /PRNewswire/ -- Provisio
Medical, Inc. today announced the formation of a Physician Advisory
Board (PAB) comprising a multidisciplinary group of physicians who
will provide input and feedback on product development decisions,
outcome- focused clinical studies and therapeutic applications of
Provisio's core Sonic Lumen Tomography™ Intravascular Ultrasound
(SLT IVUS™) technology for the approximately 20 million people in
the U.S. with peripheral artery disease1.
Members of the Physician Advisory Board include:
David Deaton, MD, FACS
Zola N'Dandu, MD, FACC, FSCAI, MSVM
Mahmood Razavi, MD, FSIR, FSVM
Peter Schneider, MD FACS
Bret Wiechmann, MD
(Detailed bios are available at:
https://provisiomedical.com/physician-advisory-board/)
Provisio Medical recently received FDA 510(k) clearance for the
ProvisioTM SLT IVUSTM System. SLT IVUS
addresses a critical unmet need for vascular specialists by
providing automatic, real-time, accurate, numeric measurements of
the flow lumen of blood vessels without the complexities of image
interpretation. Provisio Medical's catheter is the world's first
integrated intravascular imaging and support crossing catheter
and enables vessel lumen measurement and visualization
simultaneously with guidewire support and delivery of radiopaque
contrast agents.
"We are honored to draw upon the expertise of such a
distinguished multidisciplinary group of physicians to continue our
mission of improving endovascular interventions," noted S.
Eric Ryan, MD, Chief Executive
Officer. "We will rely upon each member's unique background,
clinical area of focus and interest, as well as the dynamics of
their care setting, in guiding strategic decisions for the
company."
"I am thrilled to be working closely with Provisio Medical on
the development of SLT IVUS technology. This collaboration
underscores our commitment to pushing the boundaries of medical
innovation and improving patient care together," Dr. N'Dandu
commented. "I look forward to collaborating with my colleagues from
all the different specialties in this endeavor."
Dr. Deaton further notes, "Precision in endovascular techniques
has a profound impact on outcomes and is sadly lacking in current
practice. A platform that enables clinicians' visibility and
access to precise measurements, without disrupting conventional
workflows, has the potential to transform outcomes and our ability
to study and understand the therapies we employ."
____________________________
|
1 Yost, Mary
L., The True Prevalence of PAD and the Economics of Major
Amputation, Endovascular Today, May 2021
|
About SLT IVUS™
The Provisio SLT IVUS System consists of the SLT IVUS™ P1 System
and the SLT IVUS™ Support Crossing Catheter. The SLT IVUS Support
Crossing Catheter is an over-the-wire intravascular ultrasound
catheter with an ultrasound transducer array at the distal end that
also functions as a support crossing catheter. The information from
the ultrasound signal is used similarly to sonar technology to
measure vessel dimensions in real-time and measure the peripheral
vessel's flow lumen.
About Provisio Medical
Provisio Medical is a medical device company based in
San Diego, California seeking to
establish a new standard in vessel sizing, a critical step in
millions of endovascular procedures performed every year.
Provisio's SLT IVUS™ technology, which is incorporated into the
type of catheters that physicians are already using, is designed to
revolutionize interventional therapies by giving physicians the
exact information that they need, when they need it, while
enhancing procedural workflow.
www.provisiomedical.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/provisio-medical-announces-physician-advisory-board-302136177.html
SOURCE Provisio Medical, Inc.